Alaunos Therapeutics Inc. (TCRT) at a glance

Alaunos Therapeutics Inc. (TCRT) is a micro-cap Healthcare company. It trades at $2.07, with a 0% profit margin and revenue decline of 100%. It does not pay a dividend. Vestovix scores it 43/100 overall. Its strongest dimension is Safety (86/100) and its weakest is Growth (11/100). It is a relatively defensive holding with below-market volatility.

Price

$2.07

Market cap

$5.5M

P/E ratio

n/a

Dividend yield

None

Beta

-1.06

52-week range

$1.67 to $6.20